Echo IQ is advancing its cardiac AI programs through FDA review and hospital partnerships, suggesting a focus on AI solutions for heart-related conditions.
- Condition
- Cardiac Conditions
- Sells to
- health systems
- FDA
- unknown
- Studies
- unknown
Health AI companies built around one condition — who they sell to, FDA status, and published studies.
Compiled from company sites, FDA databases, and PubMed.
Echo IQ is advancing its cardiac AI programs through FDA review and hospital partnerships, suggesting a focus on AI solutions for heart-related conditions.
a2z Radiology AI expands its acute care suite with 10 newly cleared findings, indicating a focus on AI-powered diagnostic tools for urgent medical conditions.
AI care coordination for stroke and vascular disease; FDA-cleared, sold to health systems.
FFR-CT analysis of coronary disease; FDA-cleared, sold to hospitals and cardiology groups.
Always-on radiology AI for acute findings across CT; FDA-cleared, sold to health systems.
LumineticsCore (IDx-DR) autonomously detects diabetic retinopathy; FDA-cleared.
Handheld ultrasound with AI guidance; FDA-cleared probes sold to clinicians and systems.
Kardia personal ECG with AI rhythm detection; FDA-cleared, sold direct and via employers.
AI pathology for clinical trials and diagnostics; sold to labs and biopharma.
Ambient AI medical scribe sold to health systems; enterprise contracts, not consumer.
No records match your filters yet.
Vertical AI Healthcare profiles health AI vendors by clinical condition. Each profile links to primary sources.